Podcasts about MDMA

In this episode, Psychedelic Medicine Podcast host, Dr. Lynn Marie Morski, provides the latest updates from the field of psychedelic medicine. Dr. Morski discusses the breakthrough therapy designation which a number of psychedelic compounds have received in the past few years, the most recent of which is BPL-003, a nasal spray formulation of 5-MeO-DMT. One of the exciting aspects of this new compound, Dr. Morski notes, is that it is shorter-acting than most serotonergic psychedelics—a feature which may make treatment with this substance less expensive and more accessible.  Another exciting development is the COMPASS Pathways phase 3 trial of COMP360 psilocybin. Dr. Morski shares that the company believes they are nine to twelve months ahead of schedule, which means that if all goes well, this psilocybin compound could be approved for treatment resistant depression as early as sometime in 2027. She also discusses why the US FDA said they rejected MDMA for PTSD and what this governing body would like to see from subsequent research before reconsidering this decision. In closing, Dr. Morski shares excitement about the development of novel psychoplastogens—the non-hallucinogenic psychedelics—which may help bring many of the same healing benefits to populations currently unable to be served by the existing compounds under investigation.   In this episode, you'll hear: Which psychedelics currently have breakthrough therapy designation and for which indications Details of recent ketamine research for inpatient depression care and why these results are not as negative as they may seem The current horizons of psychedelic research and what indications may soon be explored Sources of hope in the current state of psychedelic research and the legal landscape   Quotes: "[BPL-003] showed rapid and durable antidepressant outcomes after a single dose. … here we have something that is under an hour [of psychedelic experience] for treatment resistant depression." [7:43] "Keeping patients blinded to whether or not they got the placebo or MDMA is a big focus that [the FDA] wanted to emphasize for these future phase 3 trials." [19:07] "I know we had a big setback last year. I think a lot of us thought by this time we'd be a year into MDMA being approved and we're not. However, there are so many things on the horizon that are worth being excited about." [23:48]   Links: Psychedelic Medicine Podcast on Instagram Psychedelic Medicine Podcast on YouTube Jelovac A, McCaffrey C, Terao M, et al. "Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical Trial" JAMA Psychiatry, 2025. Beckley Psytech Limited Phase 2 Trial: BPL-003 Efficacy and Safety in Treatment Resistant Depression COMPASS Pathways Phase 3 Trial: Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD Food and Drug Administration (FDA) Complete Response Letter (CRL) to Lykos Therapeutics, declining to approve MDMA-assisted therapy for Posttraumatic Stress Disorder Psychedelic Alpha Psychedelic Drug Development Bullseye Chart Psychedelic Medicine Association Porangui

“I realized that rather than talking one-to-one with patients in the exam room, you could talk one-to-many on social media,” says Dr. Kevin Pho, explaining the origins of KevinMD, the highly influential information sharing site he created for physicians, medical students and patients twenty years ago. Since then, KevinMD has become a valuable space for clinicians and patients to share stories and perspectives on topics from burnout and moral injury to technology and trust. In this conversation with Raise the Line host Michael Carrese, Dr. Pho reflects on the dual paths that have defined his career: as a practicing internal medicine physician and as one of healthcare's most trusted online voices. And despite the challenges of doing so, Dr. Pho encourages other medical providers to follow his lead. “Patients are going online, and if physicians are not there, they're going to get information that's perhaps politically-driven or simply inaccurate.”This thoughtful conversation also explores: How social media has reshaped health communicationThe risks and rewards for clinicians of having an online presence Why medical schools should teach negotiating skillsMentioned in this episode:KevinMDEstablishing, Managing and Protecting Your Online Reputation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comIn this fascinating episode, Dr. Gabrielle Lyon talks with neuroscientist Dr. Ben Rein, PhD (author of Why Brains Need Friends), about the science of social connection, emotion, and cognitive health. Dr. Rein, an expert in neurobiology and psychedelic research, reveals the cutting-edge studies that explain why loneliness is as damaging as smoking and how our digital world is affecting our brain's ability to connect.They discuss the neurochemistry of love, the controversial use of MDMA in therapy, and whether AI can ever truly replace human intimacy. This conversation provides an essential look at the biological drivers of happiness, performance, and long-term brain health.Chapter Markers:0:00 - MDMA (Molly): The History & Therapeutic Benefits 5:59 - The Legal Status of MDMA for PTSD 6:44 - The Safety and Effectiveness of MDMA in Clinical Trials 8:29 - PTSD (The Amygdala Alarm) 9:41 - How MDMA Soothes the Amygdala to Access Memory 11:42 - Is There an Alternative to MDMA? (Ketamine's Mechanism) 13:16 - Ketamine and Neuroplasticity for Depression 15:48 - Botox and Empathy: 18:12 - The Problem of Volume: How Screens Depersonalize Interaction 19:48 - The Virtual Disengagement Hypothesis Explained 25:00 - Defining Cognitive and Emotional Empathy 29:43 - MDMA's Link to Serotonin & Social Reward 31:04 - Do SSRIs Have Pro-Social Effects? 36:10 - The Science of Likability and "Easy to Read" Faces 40:10 - Top 3 Ways to Be More Likable49:49 - The Likability Gap: Why You Underestimate How Well-Liked You Are 56:59 - The Neurobiology of Oxytocin, Dopamine, and Serotonin1:09:23 - The Goldilocks Zone of Empathy 1:15:58 - Narcolepsy 1:18:16 - Alcohol: Why the Neurotoxin is Bad for Brain Health 1:21:47 - Exercise and Neurogenesis1:22:27 - Sex, Orgasm, and Oxytocin Release 1:25:06 - Oxytocin During Childbirth Who is Ben Rein:Dr. Ben Rein is an award-winning neuroscientist and Chief Science Officer of the Mind Science Foundation, where he supports early-career researchers in neuroscience. He earned his PhD from SUNY Buffalo and completed postdoctoral training at Stanford University, publishing over 20 peer-reviewed papers on autism, empathy, MDMA, and digital behavior. Recognized by the NIH, the Society for Neuroscience, and Sigma Xi, he also serves as a scientific advisor to more than 20 organizations. With over one million followers and 75 million video views, Dr. Rein is celebrated for making neuroscience accessible to the public and has been featured by outlets such as Good Morning America, ABC News, and PopularMechanics.Thank you to our sponsors:BodyHealth: Use code LYON20 to get 20% off your first order https://www.bodyhealthaffiliates.com/73L4QL3/7XDN2/BON CHARGE Holiday Sale https://boncharge.com for 25% off Pique 20% off for life: https://Piquelife.com/DRLYONFind Ben Rein at: Website: https://www.benrein.com/Instagram: https://www.instagram.com/dr.benrein/#TikTok: https://www.tiktok.com/@dr.benrein?lang=enFacebook:

Clinical psychologist Dr. Genesee Herzberg joins Kyle to reflect on two decades in trauma work and 15 years inside the psychedelic ecosystem—from early MAPS conferences to running Sage Integrative Health. She traces how personal psychedelic experiences set her on a path of service, research at CIIS on MDMA-assisted therapy, and hands-on roles with MAPS: Zendo Project harm reduction, adherence rating, and ultimately serving as an MDMA therapist in clinical trials. Today she leads Sage, an integrative clinic (psychotherapy, psychiatry, bodywork, acupuncture, and functional nutrition) focused on ketamine-assisted therapy while preparing for MDMA's eventual approval. She also co-founded a sliding-scale KAP nonprofit (now Alchemy Community Therapy Center), co-edited Integral Psychedelic Therapy, and is helping to launch the International Alliance of MDMA Practitioners. In this episode From counterculture to mainstream: What's been gained—and lost—as psychedelics scaled. Accessibility vs. corporatization: Why cutting corners (prep/integration, therapeutic time) undermines outcomes and safety. "Myth of the magic pill": Psychedelics can catalyze change, but healing is an ongoing process anchored by integration. What good care looks like: Preparation → medicine sessions → robust integration, individualized cadence, and adding bodywork and functional medicine to address gut-brain links, mineral status, sleep, and somatic tension. Ketamine realities: Differences between psycholytic (talk-forward) and psychedelic (eyes-closed, inner-directed) dosing; why some need multiple sessions to build relationship with the medicine; risks of mail-order models (high dosing, poor screening/support), daily prescribing, addiction potential, cystitis, and safety concerns. Sitting, not guiding: The therapist's task is to follow the client's process; intervene sparingly and with consent—especially in trauma work where attuned co-regulation is essential. Multiple access pathways: Support for regulated clinical care and community, peer, and ceremonial models—paired with education and harm reduction (Zendo's SIT peer training and new crisis-responder training). The MDMA pause: Initial devastation at the FDA decision gave way to seeing benefits: time to strengthen ethics, accountability, training standards, and to temper hype-driven investment. Pace and ethics: Lessons from burnout; moving at the speed of trust; exploring "psychedelic business models" (stakeholder focus, distributed decision-making, employee ownership, public benefit structures). Resources & organizations mentioned Sage Integrative Health Alchemy Community Therapy Center (sliding-scale KAP) International Alliance of MDMA Practitioners Integral Psychedelic Therapy (edited by Genesee Herzberg, Jason Butler, Richard Miller) Takeaway: Thoughtful preparation, right-sized dosing, and committed integration—held within ethical, community-minded systems—turn powerful experiences into durable change.

“We've created this ecosystem where the vast majority of information on social media, particularly in nutrition science, is inaccurate or misleading,” says Dr. Jessica Knurick, a registered dietitian and Ph.D. in nutrition science specializing in chronic disease prevention. As you'll learn on this episode of Raise the Line with host Lindsey Smith, countering that trend has become Dr. Knurick's focus in the past several years, and her talent for translating complex scientific information into practical guidance has attracted a large following on social media. Beyond equipping her audience with the tools to think critically and make informed choices for themselves, she also wants them to make the connection between the generally poor health status of most Americans with public policies on food and health and advocate for more beneficial approaches. “We can create systems that put the most people in the position to succeed versus putting the most people in the position to fail.” Tune in to learn from this trusted voice on nutrition, food policy, and public health as she shares her perspectives on: Strategies for risk reduction and behavior changeWhat can rebuild trust in medical information How you can cut through the noise and spot misinformation onlineMentioned in this episode:Dr. Knurick's WebsiteTikTok ChannelInstagram FeedFacebook Page If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Episode 10 - Stephanie Karzon Abrams: Heart and Science This episode takes on a wide ranging ride inside Stephanie's wildy diverse experise on the science of psychedelics to the importance of music and community. Stephanie is a profound and powerful voice in the psychedelic community and her work represents the best of the modern psychedelic movement.  Intro: Ann Shulgin takes on a brief exploration of the shadow.  Stephanie Karzon Abrams is a neuropharmacologist, founder of Beyond Consulting—powering the integrative, psychedelic and plant medicine spaces, and is the co-founder of the Public Secret music label and artist collective.  She serves as Clinical Director at Modern Medicine Services, is a prescriber of MDMA and psilocybin therapy under Canada's SAP, and is the Research Director at the Microdosing Collective non profit.  Stephanie believes in the undercurrent of joy woven into the fabric of our existence and thus co-created the talk and event series "The Chemistry of Joy", where the human experience is explored through the lens of ritual and celebration.  With experience in neurology, intensive care, and medical device at Johnson & Johnson, she is a recognized leader in innovative healthcare. Her work bridges neuroscience, women's health, plant medicine, and the healing power of music. A musician, writer, and speaker, Stephanie also builds community through gatherings rooted in music, meaning, and mycology. Web: https://www.stephaniekarzonabrams.com  Www.Beyondconsulting.Life  Social: @steph__k @public.secret  @microdosingcollective @thechemistryofjoy @mod_meds

Andrew Humberman BioSnap a weekly updated Biography.In the past few days Andrew Huberman has been front and center in the neuroscience and wellness spheres with both academic rigor and broad public reach. The most notable headline is the November 6 release of his Huberman Lab Essentials episode called “Erasing Fears and Traumas Using Modern Neuroscience,” where Huberman dives into how deliberate daily practices—like five minutes of cyclic hyperventilation—can rewire the brain's fear responses. He breaks down the neural circuits involved, citing the amygdala and dopamine systems, and offers evidence-based strategies such as prolonged exposure therapy, cognitive behavioral approaches, and even discusses the cutting edge use of ketamine and MDMA for PTSD. The episode quickly climbed the podcast and YouTube ranks, reflecting significant engagement and concrete potential for impact in clinical and lifestyle settings.On the business front, Huberman continues to steer his expanding empire across media, science, and health optimization. His podcast remains the number one health and fitness show on Apple and Spotify, frequently featured in best-of charts. Recent social media posts on Instagram and X highlight his protocols for sleep, stress management, and metabolic health, drawing thousands of likes and repeated enthusiastic comments lauding his ability to make science accessible and actionable. Subscribers to his newsletter, now nearing one million, received exclusive insights this week including what's dubbed the “Daily Blueprint”—detailing Huberman's own routine with practical steps for productivity and wellbeing.Meanwhile, his new book “Protocols” remains highly anticipated in pre-order status, billed as a definitive guide for improving brain function and overall health through habits and biochemical interventions. In industry news, ABC World News Tonight covered Huberman's appearance to discuss “10 Habits You Must Improve Every Day to Rewire Your Brain,” bringing his science-backed advice to a mainstream television audience. This appearance has further elevated his pop culture status as a go-to authority on optimizing mental performance and resilience.Within academic circles, Huberman is referenced in discussions alongside Dr. David Sinclair on the topic of slowing aging, with his perspectives on neural plasticity and longevity gaining ground in medical and scientific media outlets. While his recent stance on drug repurposing for neurological and immune conditions was spotlighted via collaboration with Dr. David Fajgenbaum, this continues a trend of merging clinical discovery with public education and advocacy.Rumors have circulated about upcoming public appearances, potentially including a keynote at a major veterans' mental health gala next week, though this is not yet confirmed and should be treated as speculation. There has been no verified controversy or negative press in the last few days, and feedback remains overwhelmingly positive. In short, the biographical stakes for Huberman have only grown—his accessibility, practical expertise, and ever-expanding audience reinforce his status as a primary architect at the intersection of neuroscience and everyday life.Get the best deals https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI

In this Huberman Lab Essentials episode, I explore the neuroscience of fear and trauma and how to effectively process and eliminate traumatic responses. I explain why successful fear treatment requires both extinction of the old fearful response and replacement with a new positive association—not just cognitive reframing. I also explain how the threat reflex activates specific circuits connecting the amygdala, prefrontal cortex, and dopamine systems, and why detailed recounting of traumatic events progressively reduces their physiological impact. Finally, I review evidence-based approaches, including prolonged exposure therapy and cognitive behavioral therapy, discuss how five minutes per day of deliberate stress through cyclic hyperventilation can rewire fear responses, explain the critical role of social connection in activating neural pathways that reduce trauma, and share supplementation options for managing anxiety. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman LMNT: https://drinklmnt.com/huberman Function: https://functionhealth.com/huberman Timestamps (0:00) Introducing Fear & Trauma (0:17) What is Fear? (1:03) Autonomic Arousal: "Alertness" vs. "Calmness" (2:05) Fear vs. Stress & Anxiety (9:20) "The Threat Reflex": Neural Circuits for Fear (20:50) Cognitive (Narrative) Therapies for Fear (26:35) PTSD Treatments: Ketamine, MDMA, Oxytocin (33:11) Deliberate Brief Stress Can Erase Fears & Trauma (35:51) Nutrition, Sleep, & Other General Support Erasing Fear & Trauma (38:18) Recap Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

Dimitri and Khalid speak with Brian Normand, Russell Hausfeld, and Brian Pace from the psychedelic watchdog group Psymposia about their excellent new 200+ page report, “The Psychedelic Syndicate”. Other topics discussed: how and why Psymposia became the psychedelic industry's anointed scapegoat after the FDA rejected MDMA-assisted therapy in 2024, Hamilton Morris's defamatory and weirdly misogynistic attacks on Psymposia in his recent Channel 5 interview, the rapid ascendance of a right-wing techno-capitalist psychedelic culture over the last 5-10 years, the billionaire-stuffed PSFC money network that took over MAPS, why handing Peter Thiel, Rebekah Mercer, and Kimbal Musk a for-profit psychedelic therapy monopoly in 2025 might be a bad idea, using military veterans as a sympathetic smokescreen to ram pseudoscientific Grofian therapeutic protocols through regulatory agencies, Steve Jurvetson's post-MeToo fever dreams of building an AI-assisted psychedelic pro-capitalist Burning Man Gaia religion, and what it's like facing a coordinated onslaught from the entheogenic mafia of MAPS/Esalen New Agers, Silicon Valley technofascists, one-shotted heirs of Great American Fortunes, duplicitous New York Times reporters, and astroturfed “veterans' groups” who are seeking to define and control the future of psychedelic use across the American empire. Read “The Psychedelic Syndicate” report here: https://www.psymposia.com/psychedelic-syndicate-executive-summary-silicon-valley-maps-lykos-mdma-fda-billionaires/ For access to premium SJ episodes, upcoming installments of DEMON FORCES, and the Grotto of Truth Discord, subscribe at https://patreon.com/subliminaljihad.

Could studying the DNA of extinct animals – or even bringing them back to life – help us save today's endangered species and inform modern medicine?  That may sound like the premise for a Hollywood movie, but it's work that our Raise the Line guest, Dr. Beth Shapiro, is actually engaged in as Chief Science Officer at Colossal Biosciences, which describes itself as the world's first and only de-extinction company.  “It's not just about learning about the past. It's learning about the past so we have more validated scientific information that we can use to predict what we can do to better influence the future,” she tells host Michael Carrese. An internationally-renowned evolutionary molecular biologist and paleogeneticist, Dr. Shapiro is a pioneer in ancient DNA research and has successfully sequenced genomes, like that of the dodo, to study evolution and the impact on humans. At Colossal Biosciences, she leads teams working to bring back traits of extinct species such as the mammoth, not for spectacle, but to restore ecological balance. “When species become extinct, you lose really fundamental interactions between species that existed in that ecosystem. By taking a species that's alive today and editing its DNA so that it resembles those extinct species, we can functionally replace those missing ecological interactions.” Tune into this utterly fascinating conversation to hear about what Jurassic Park got wrong, the positive ecological impact of reintroducing giant tortoises to Mauritius, and the ethics of using gene editing and other biotechnologies. Mentioned in this episode:Colossal Biosciences If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Diese Folge auf YouTube ansehen und den YouTube Kanal abonnieren, um keine neue Folge mehr zu verpassen.ZusammenfassungIn dieser spannenden Episode begrüßt Julia Psychotherapeutin Eva Gallacher, Expertin für Psychedelika in der Psychotherapie. Eva teilt ihren persönlichen Weg zu diesem lange stigmatisierten Thema und enthüllt, dass sogar der Gründer ihrer Psychotherapieschule, Hanscarl Leuner, bereits intensiv mit psychedelisch-assistierter Therapie gearbeitet hat. Wir beleuchten, warum neue Therapieansätze so dringend benötigt werden, insbesondere für Patienten mit therapieresistenter Depression, Angststörungen und posttraumatischer Belastungsstörung (PTBS), bei denen herkömmliche Behandlungen oft an ihre Grenzen stoßen.Eva erklärt die faszinierende Geschichte der Psychedelika Psychotherapie, von der Entdeckung des LSD durch Albert Hofmann bis zum "War on Drugs" in den 1960er Jahren, der die vielversprechende Forschung für Jahrzehnte zum Erliegen brachte. Sie räumt mit Vorurteilen auf und vergleicht die tatsächliche Gefährlichkeit von Psychedelika mit anderen Substanzen wie Alkohol, basierend auf Studien von David Nutt. Klassische Psychedelika wie LSD und Psilocybin zeigen dabei ein geringes Abhängigkeitspotenzial. Wir tauchen ein in die Wirkweisen verschiedener Substanzen – von klassischen Psychedelika, die am Serotonin-Rezeptor ansetzen, über MDMA als Entaktogen bis hin zu Ketamin, das bereits legal bei Depressionen eingesetzt wird.Ein zentrales Thema ist der rechtliche Status: Während in der Schweiz seit über zehn Jahren individuelle Bewilligungen für psychedelisch-assistierte Therapien möglich sind und Tschechien Psilocybin ab 2026 legalisiert, steht Österreich noch am Anfang. Eva betont die absolute Notwendigkeit einer professionellen, gut strukturierten Therapie, die aus Vorbereitung, einer mehrstündigen Dosissitzung (oft mit zwei Therapeuten) und anschließenden Integrationssitzungen besteht. Es wird klar, dass dies keine "Wunderpille" ist, sondern intensive therapeutische Arbeit erfordert, bei der auch schwierige Erfahrungen zu den wertvollsten Einsichten führen können. Die Rolle des Therapeuten ist dabei entscheidend, um einen sicheren Rahmen zu gewährleisten. Eva spricht auch über wichtige Kontraindikationen wie Psychosen oder bestimmte Herzerkrankungen und die Arbeit der neu gegründeten APSTA in Österreich, die sich für Aufklärung und die Zukunft dieser Therapieformen einsetzt.Unterstützt durch higherQIWissenschaftlich fundierte Fotobiomodulation für zuhause!✨ 660nm Rotlicht + 850nm Nahinfrarot kurbeln die Energieproduktion eurer Zellen an. Optimal wirksam in 15cm Abstand, täglich 15-20 Minuten morgens oder abends.

Ospite della 182° puntata di Illuminismo Psichedelico, andata in scena il 26 ottobre al Circolo Arci di Settignano (Firenze) è il professor Bruno Neri, docente del dipartimento di Ingegneria dell'Informazione dell'Università di Pisa, che negli ultimi anni ha svolto una serie di studi presso l'insediamento Tibetano di Bylakuppe, in India. Il professor Neri è stato ospite dell'Università monastica di Sera Jey, nell'ambito di una convenzione di studio e ricerca con l'Ateneo pisano, l'attività di indagine di Bruno Neri ha avuto come oggetto l'analisi degli effetti degli stati non ordinari di coscienza indotti mediante pratiche meditative sull'attività cerebrale. In questa puntata, oltre ai risultati del suo lavoro, abbiamo parlato di stati espansi di coscienza (meditazione profonda, tantra, psichedelia ed esperienze di premorte), modelli di coscienza e stati espansi, partendo dal lavoro del capostipite della psicologia statunitense, William James; e delle esperienze di Federico Faggin, partendo dal suo concetto di mente quantica.

According to the Bloomberg School of Public Health at Johns Hopkins University, women make up 70% of the global healthcare workforce but hold only about 25% of leadership positions. Our guest today on Raise the Line, Dr. Roopa Dhatt, has been a leading voice in the movement to correct that imbalance through co-founding an organization called Women in Global Health (WGH), which has established chapters in over 60 countries since it started a decade ago. Dr. Dhatt is also pursuing that agenda and addressing other pressing issues in healthcare as a Young Global Leader at the World Economic Forum. “We're changing the equation so women delivering health are also viewed and valued as leaders,” says the internal medicine physician and assistant professor at Georgetown University School of Medicine. Beyond leadership equity, Dr. Dhatt is also seeking to address systemic pay inequities and high levels of violence and harassment experienced by women in the health sector, issues that were highlighted in research conducted by WGH. Although WGH has seen high-level success influencing policy at the World Health Organization and United Nations, Dr. Dhatt says the heart of its success is local. “Women community health workers have begun to see themselves as leaders and the heroines of health in their communities. That's profound change.” Join host Michael Carrese for a probing conversation that identifies the structural barriers blocking advancement for women and that explains why the health of communities and the planet depend on inclusive leadership.Mentioned in this episode:Women in Global HealthWHO Report: Delivered By Women, Led By MenDr. Roopa Dhatt on LinkedIn If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

112. Epidemic of Fear: How Psychedelics Help Us Transcend StucknessDiscover how psychedelics help retrain the nervous system to move from fear to flow. April Pride explores the roots of stuckness, the Hero's Journey, and how microdosing and macrodosing support nervous system healing.

Rachael, a trauma therapist and today's storyteller, describes how her early childhood abuse was buried by the protective mechanism of dissociative amnesia.  As Rachael wrote to Dr. H, “The only way I could continue to live, with no way out, with no one to tell, with no words even to describe what was happening to me, was to forget what was happening to me….when our minds forget, our bodies remember.”Rachael saved herself by forgetting, then was forced to finally face what happened to her when her body carried out its ultimate rebellion in the context of having her third child, her first girl….a little baby girl, with no one to protect her….or at least that's what the terrible and unrelenting obsessions began to say.Support the show! https://www.buzzsprout.com/396871/supportRachael Parsons Svendsenhttps://www.rachaelsvendsen.com/"I Love You, I Hate You, Are You My Mom?"  An intensive experiential workshop exploring transference with Dr. H and Dr. Hillary McBride, Feb 4th-6th 2026 in Joshua Tree, CA https://www.craigheacockmd.com/i-love-you-i-hate-you-are-you-my-mom/BFTA episode recommendations/Podcast pagehttps://www.craigheacockmd.com/podcast-page/Support the show

“Psychedelics trigger a unitive state, and meditation trains it.”So says Naina Eira Gupta, who researches the therapeutic potential of psychedelics and meditation.Psychedelics work because they disrupt the monkey mind, she asserts. They stop the constant chattering in your head, which is the mind's MO to perpetuate the story of ‘you'.Everything we think we have is just that, a story.“Psychedelics are assisted mind training, I would call it. They provide mental immunity”, says Naina.Then, meditation trains you to keep that base perception, to see the story for what it is.“You realize you don't have to be reactive to a particular thought or feeling, because it's just a story.“When the ego dissolves, you become so much more of an effective human being.“You can fall in love with the world. Everything becomes lighter. You don't feel so much distance between what you perceive as ‘you' and the rest of it.”What Naina hopes for is that more people have access to mind training, “because it's deeply, deeply transformative”.Different psychedelic drugs work in different ways. Some can trigger negative experiences if taken irresponsibly. According to Naina, MDMA is one of the best for pro-sociality and connectedness, because it produces very little bad experiences.Psychedelic experiences can be so transformative that it can be difficult to know what to do with them. Some kind of scaffolding around their use is needed, says Naina.“Even so, many studies now show that psychedelics are beneficial therapeutically, even just in themselves, even if you don't have a particular practice around them.”As a practicing Buddhist, Naina Gupta doesn't hold a certain metaphysics. The middle way means that you accept that reality cannot be framed or pinned down. Something is, isn't, is both and is neither, at the same time.“It's just unbelievable potential.”The cause of our suffering is the subject-object duality.Naina has several meditation practices, and she has trained herself to dream lucidly.Is this – learning how to liberate oneself from duality with the help of psychedelics, meditation and other spiritual practices – conducive to achieving a more peaceful world?“If there is any hope, it lies in this.”“I wouldn't be talking to you today if this wasn't needed.”Naina's personal page at the University of ExeterNaina on Linkedin

My first experience mixing all of these delicious fruits together made for an experience that I'll never forget. Instagram► instagram.com/imtrippin2hardTiktok► https://www.tiktok.com/@imtrippin2hard?_t=ZT-8yT1f2CO2FD&_r=1Spotify►https://open.spotify.com/show/5i24lc5DEMbxR6SwVzLn3F?si=Xvm9nA3FTMmTlknsDAupZQEmail► imtrippin2hard@gmail.comConsciousness Playlist►  https://youtube.com/playlist?list=PL_0q8zQRycjQ3yfxBESjr3zTdirSQ19OC&si=m7WI9_BY5YVpOwykYouTube►https://www.youtube.com/c/TRiPPN This video is for educational and entertainment purposes only. Always research, practice harm reduction and follow your local laws.© TRiPP!NSend me a message! Support the show

In this episode, Dr Tsen Vei Lim talks to Zachary Bryant, a PhD candidate at the Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Australia. The interview covers Zachary's research report on the relationship between MDMA (or ecstasy) use in youth adulthood and anxiety or depressive disorders in later adult life. The effects of MDMA [1:20]The prevalence of MDMA use and reasons why people take it [02:00]The relevance of MDMA for depression and anxiety [03:05]The use of the Victorian Adolescent Health Cohort Study to answer Zachary's research question [04:17]The key findings of the study [06:50]Some reasons to explain the relationship found between MDMA use and anxiety but not depression [07:43]The self-medication hypothesis [10:04]The implication of the findings for clinical practice [11:02]The importance of replicating the findings in different cohorts and with more recent data [14:03] About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK). About Zachary Bryant: Zachary is a PhD candidate and research officer at the University of Sydney's Matilda Centre for Research in Mental Health and Substance Use. His doctoral research examines the relationship between MDMA (ecstasy) use and mood, with a focus on implications for therapeutic applications. More broadly, his work explores the epidemiology of psychedelic use and applies advanced causal approaches to substance use research. He is particularly interested in emerging data collection and analysis methods, including intensive longitudinal designs such as Ecological Momentary Assessment (EMA).The authors have no conflicts of interest to disclose. Original article: The relationship between 3,4-methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid-30s: Findings from the Victorian Adolescent Health Cohort Study - https://doi.org/10.1111/add.70173The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

“They say it takes a village to raise a child. I really think it takes a village to treat a patient,” says Dr. Lanae Mullane, a naturopathic doctor and clinical strategist who has spent years at the forefront of bridging functional medicine, nutraceutical development, and digital health. In this episode of Raise the Line, host Lindsey Smith explores Dr. Mullane's view that naturopathic medicine complements conventional care by expanding -- not replacing -- the clinical toolkit, and that collaboration should be the future of medicine. “At the end of the day, collaboration and connection create the best outcomes for the people we serve,” she says. Their in-depth conversation also spans the shifting landscape of women's hormone health, including the perimenopausal transition and long-overdue calls for research equity. “We're not just smaller versions of men. We need to have dedicated research for us.” Tune in to learn about the importance of grounding health in sustainable habits, rethinking midlife care for women, and how to help patients take ownership of their health.Mentioned in this episode:Joi + BlokesSuppCoDr. Mullane's Clinical Website If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this episode of the Atomic Anesthesia Podcast, we tackle the complex reality of caring for patients under the influence of drugs or alcohol, a frequent challenge for nurse anesthesia residents and CRNAs. Covering the physiological effects and anesthetic implications of acute and chronic intoxication with alcohol, benzodiazepines, hallucinogens (such as LSD, PCP, and MDMA), cocaine, and cannabinoids, this episode offers fast, practical guidance for optimizing perioperative care and minimizing patient risk. Listeners will learn how substance use alters anesthetic requirements, impacts drug metabolism, and poses unique airway and hemodynamic risks, while also receiving actionable tips for drug class-specific management like when to use or avoid certain agents, the importance of invasive monitoring, and strategies for handling withdrawal or overdose. Tune in for a high-yield rundown that will help you make safer decisions when handling intoxicated patients in the OR.Want to learn more? Create a FREE account at www.atomicanesthesia.com⚛️ CONNECT:

בפרק זה מארח גיא קצוביץ' את עומר זרחיה, שקיבל רישיון ממשרד הבריאות להקמת מתקן לגידול וייצור של פטריות פסילוסיבין (פטריות פסיכדליות). בפרק מטלטל הוא מסביר כיצד הפטריות ו-MDMA מסייעות במצבים של דיכאון, פוסט טראומה ו-OCD, ולמה חומרים אלו הוצאו מהחוק למרות יעילותם שהוכחה בניסויים קליניים ובבתי חולים. (00:00) - פתיחה(03:07) - קנאביס רפואי בישראל(09:06) - ההיסטוריה של הפסיכדליה: למה יצא להם שם רע?(14:51) - חומרים פסיכדליים בישראל(25:05) - טיפול בפוסט טראומה(39:06) - כך נראה טיפול עם פטריות(48:44) - הסיכונים והסיכויים בטיפול פסיכדלי

Katie Treble grew up crying at about how all the king's horses and men couldn't put Humpty Dumpty together again. It was that compassion that made her the perfect candidate for doctoring during war as an adult.When Dr Katie Treble decided to swap the good vibes and beautiful beaches of Byron Bay for work with Médecins Sans Frontières (MSF) she knew she would be in for a shock. Nothing could have prepared her for the desperate need she encountered in the Central African Republic (CAR) in the midst of a civil war.But Katie was even more affected by the courage and kindness of her colleagues.She came away from her months in Bria, CAR knowing that her time as a humanitarian doctor would change her own life in deep ways, and so when she got back to Australia she started the work of trying to make sense of it all.Field Notes from Death's Door is published by HarperCollins.This episode of Conversations was produced by Meggie Morris, executive producer is Nicola Harrison.It explores medicine, university, war, civil war, Africa, humanitarian crisis, Gaza, Israel, Palestine, MSF, doctors without borders, access to medicine, hospital, conflict zones, PTSD, malaria, defence, navy, Kenya, France, Jamaica, Haiti, natural disaster, murder, infant mortality rate, vaccination, religious war, Islam, Christianity, genocide, MDMA therapy, psychology, recovery, healing.To binge even more great episodes of the Conversations podcast with Richard Fidler and Sarah Kanowski go the ABC listen app (Australia) or wherever you get your podcasts. There you'll find hundreds of the best thought-provoking interviews with authors, writers, artists, politicians, psychologists, musicians, and celebrities.

Wil Fisher is a San Diego based spiritual life coach and retreat leader dedicated to helping folks live lives of authenticity, freedom and joy! Before moving to San Diego, Wil spent many years in NYC where he earned his MA in Applied Theater, performed a solo show he wrote and produced, raised money for nonprofits, co-founded a company called Man Question, and created his drag alter ego, Sylvia London. After NYC, he served as executive director of Easton Mountain, a personal and spiritual growth retreat center for LGBTQ folks. Today, in addition to hosting his podcast, Queerly Beloved, and growing his coaching business, "Willfully Living," he also teaches improv to young adults on the autism spectrum. He's also writing a book exploring using the energy and wisdom of playfulness on one's spiritual journey. Episode Highlights▶ The Radical Fairy Movement and its influence on queer spirituality▶ Wil Fisher's journey from theater and nonprofit work to spiritual coaching▶ How earth-based practices helped him reconnect with spirituality▶ The role of self-love and authenticity in personal growth▶ Integrating spiritual principles into everyday life and coaching▶ Breaking free from societal and parental programming to find your true self▶ Healing through unconventional methods, from conscious kink to MDMA-assisted therapy▶ The importance of boundaries and safety in transformative work▶ How play and joy can be powerful tools for healing and connection▶ The future of healing rooted in creativity, self-expression, and communityWil Fisher's Links & Resources▶ Website: www.wil-fullyliving.com▶ Instagram:  https://www.instagram.com/wilfish99/▶ TikTok:  https://www.tiktok.com/@queerspirit▶ YouTube: https://youtube.com/playlist?list=PLH8Pj5n3XGM-7-lBnF5OtiYf3tlZERzlL&si=rk_cvNujMslJxtZf▶ Facebook: https://www.facebook.com/profile.php?id=100090026142775 Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz ▶ Join the free Psychedelics & Purpose Community: / psychedelicsandsacredmedicines

Harmony and Russell talk with researcher and author Matt Zemon about psychedelics as catalysts for change, not cures. They explore what current studies suggest about anxiety, PTSD, repetitive thinking, and addiction, then ground the conversation in practical guidance: source, set, and setting, medical intake, and the role of preparation and integration. The trio also contrasts medical and ceremonial lanes, the spiritual significance of entheogens, and how community transforms the healing arc—especially for veterans and for people navigating midlife transitions. What You'll Learn Catalyst vs. cure: why altered states create openness for change, and why integration is the practice that makes it stick Repetitive thinking patterns: how psychedelics may interrupt ruts that manifest as anxiety, depression, OCD, compulsions, or workaholism Source, set, and setting: a clear safety-first framework echoed by research institutions Preparation: clarifying intentions, tending physical space, and naming post-ceremony supports Integration: bringing insights into dishes, deadlines, and relationships, plus finding community that fits your path Medicine personalities: distinctions between ketamine, MDMA and MDA, psilocybin, LSD, ayahuasca, iboga/ibogaine, wachuma and peyote Risk basics: why independent medical consults matter, medications that conflict, and when supervised care is non-negotiable Spiritual context: clinical findings alongside living spiritual traditions, and why collaboration between science and spirit is needed now The information provided in this episode is for educational and informational purposes only. It does not constitute medical, psychological, or legal advice, and should not be relied upon as such. Psychedelic substances remain illegal in many jurisdictions, and their use carries physical, psychological, and legal risks.  If you are struggling with your mental health or substance use, please seek support from a licensed professional or contact your local mental health helpline. About Our Guest — Matt Zemon Matt holds a Master's in Psychology and Neuroscience from King's College London and is completing a Doctorate of Ministry at the Pacific School of Religion. He's the author of Psychedelics for Everyone, Beyond the Trip, and The Veteran's Guide to Psychedelics created with the Heroic Hearts Project. Matt works at the intersection of spirituality and mental health, helping communities and providers reduce risk and support meaningful, safe experiences. Resources Mentioned (pulled from the convo) Guest site: mattzemon.com Books: Psychedelics for Everyone, Beyond the Trip, The Veteran's Guide to Psychedelics Organizations and references mentioned: King's College London Pacific School of Religion Heroic Hearts Project Johns Hopkins, NYU, UCSF psychedelic research programs spiritpharmacist.com (Dr. Ben Malcolm), Dr. Emily Kopa On safety frameworks: source, set, and setting On community and faith-based contexts: Christian, Jewish, and Islamic psychedelic groups were referenced generally Call to Action Join Harmony's 21-Day Money Magic and Manifestation Challenge starting November 3 with a bonus live activation on Sunday, November 2. Check the show notes link to register, get the Manifestation Activation right away, and meet the community. Subscribe, rate, and review the show. Turn on automatic downloads. Say hello on Instagram: @findingharmonypodcast and @harmonyslaterofficial. Upcoming events: https://harmonyslater.com/events 21 Day Money Magic Manifestation Challenge: https://community-harmonyslater.com/landing/plans/1542444Use PROMO CODE for additional $20 Savings: MANIFESTATIONMAGIC  FREE Manifestation Activation: https://harmonyslater.kit.com/manifestation-activation FIND Harmony: https://harmonyslater.com/ JOIN the Finding Harmony Community: https://community-harmonyslater.com/ Harmony on IG: https://www.instagram.com/harmonyslaterofficial/ Finding Harmony Podcast on IG: https://www.instagram.com/findingharmonypodcast/ FREE 2 min breathwork practice: https://harmonyslater.com/morning-breathwork-optin Find your Spiritual Entrepreneur Archetype! Take the Quiz! https://harmonyslater.com/spiritual-entrepreneur-archetype-quiz BOOK Your Spinal Energetics Session: https://harmonyslater.as.me/

“It's kind of a miracle, frankly,” says Dr. John Buse, a distinguished professor at the University of North Carolina School of Medicine, referring to the effectiveness of GLP-1 receptor agonist medications such as Ozempic in treating type 2 diabetes, promoting significant weight loss, and reducing cardiovascular risk. As a physician scientist for the last three decades at UNC, Dr. Buse has played a key role in ushering in this new era of diabetes care, leading or participating in over 200 clinical studies on this class of drugs and others. “Nothing has impacted diabetes care like the GLP-1 receptor agonists. I have lots of patients whose diabetes was never well controlled who have seen all their metabolic problems essentially resolved.”  In this fascinating conversation with Raise the Line host Lindsey Smith, Dr. Buse not only explains how these drugs work, but also provides a clear-eyed look at side effects, and addresses issues of cost and access. Join us for the remarkable story – including the role played by Gila monsters -- behind one of the biggest developments in medicine over the past several years from a world renowned diabetes researcher and clinician. Mentioned in this episode:UNC School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this episode, we explore inner healing through altered states of consciousness. Joining me is Irina Vlada, a psychologist, author, and entrepreneur known for her pioneering work in developing holistic ketamine treatment programs that have led to profound personal transformations. Irina specializes in Psychedelics & Addiction Recovery, merging yogic tools for deeply life-transformative experiences. In the pod we talk about:·      Irina's personal journey from the Himalayan yogic tradition to psychedelics and ketamine.·      How psychedelics, spirituality, psychology, and wellness intersect for powerful inner healing. ·      How ayahuasca can facilitate profound psychological and spiritual experiences, while yoga provides the integrative framework for embodying change.·      How ketamine and yogic techniques like breathwork can synergize to create a more comprehensive healing experience. Please note! Ketamine is not a recreational drug. ·      We discuss the work of MAPS, the Multidisciplinary Association for Psychedelic Studies, researching the healing potential of MDMA and other psychedelics.The experiences expressed in this episode are purely personal and educational, and not intended for the promotion of ayahuasca, ketamine, or any other psychedelic modality.About Irina:Irina Vlada, PhD(c), Research in Psychedelics & Addiction Recovery | East West Psychology | Ketamine Integration | Awareness and Transformation Coach.She places a strong emphasis on the significance of psychedelic preparation and integration protocols to fortify the nervous system. Currently pursuing her PhD, Irina's research is centered around Neuroplasticity and Healing through altered states of consciousness. Irina's path is deeply rooted in the discovery and exploration of the authentic self. She is the co-founder of Evolve Wellness App, founder of Breathwise Coaching for personal transformation, and an Integration Coach with Mindbloom. References:https://www.instagram.com/irinavlada__/https://maps.orgThank you so much for listening, and thanks to my sponsors.This Episode is brought to you by: • The Sattva Collection - 10% off with code TheConsciousDiva• Birds & Beans Organic Coffee - 10% off with DIVA2025The Conscious Diva Podcast wouldn't be possible without your support! A massive THANK YOU for listening. If you'd like to further support my podcast, you can:• SUBSCRIBE in your favorite podcast player or YouTube.• FOLLOW me @The_Conscious_Diva on Instagram. • BOOK a session with Tatyanna.• SIGN-UP to receive emails at www.tatyannawright.com

החומר: כיצד משפיעים סוגים שונים של חומרים פסיכדלים, דוגמת פסילוסיבין ו-MDMA, על המוח האנושי? חוקר אורח: ד"ר ליאור רוזמן, חוקר פסיכדליה ומרצה בכיר באוניברסיטת אקסטר באנגליה.עורכת ומגישה: גיל מרקוביץ, עורכת: ויויאנה דייטש, תחקיר: ירין בר נוי, מפיקה: תמר בנימין, עיצוב קול: דימה קרנצובSee omnystudio.com/listener for privacy information.

Send us a textIn this episode of Small Cap Spotlight x WTR Healthcare Happenings podcast, WTR's Tim Gerdeman, and Robert Sassoon welcomes back Nick Kadysh, Founding CEO and President of PharmAla Biotech (OTCQB: MDXXF). The discussion explores the evolving global regulatory environment for psychedelics—particularly MDMA—the ripple effects of the Lykos Therapeutics FDA Complete Response Letter (CRL) disclosures, and PharmAla's strategic approach to research, manufacturing, and commercialization of clinical-grade MDMA and next-generation analogues.

“It wasn't a profession, it was a way of life,” observes internationally respected psychiatrist Dr. Nasser Loza, reflecting on a century-long family legacy in mental health care that began when his grandfather founded The Behman Hospital in Cairo. In this candid Raise the Line conversation with host Michael Carrese, Dr. Loza traces the transformation of psychiatry he's witnessed in his long career as increases in classifications, payment bureaucracy, reliance on pharmaceuticals, and technological disruption have each left their mark. The cumulative costs associated with these changes have, he laments, pushed care out of reach for many and hindered the human connection that is key to the discipline. He describes his prescription for countering these trends as a focus on effective and modest aims. “Rather than saying, come and see me in therapy for five years and I will make a better person out of you, I think focusing on symptom-targeted help is going to be what is needed.”  In this wide-ranging interview, you'll also learn about progress on advancing the rights of mental health patients and lowering stigmas, how to manage the rise of online therapy and use of AI chatbots, and the importance of empathy and transparency in mental health counseling. Don't miss this valuable perspective on a critically important dimension of healthcare that's informed by decades of experience as a clinician, government official and global advocate. Mentioned in this episode:The Behman HospitalMaadi Psychology Center If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

  In this episode, host Dr. Mike Hart welcomes neuroscientist and author Dr. Ben Rein to discuss his new book, 'Why Brains Need Friends: The Neuroscience of Social Connection.' Dr. Rein shares his journey in neuroscience, his research on autism and MDMA, and his pivot towards science communication. They delve into the devastating effects of loneliness, comparing its impact on mortality to smoking 15 cigarettes a day, and explore why human connections are critical for our brain health. Dr. Rein also discusses the benefits of having pets, the intricate balance of social interactions across a lifespan, the effects of MDMA on feelings of connection, and the role of oxytocin in social bonding. This episode provides a deep dive into the science behind social interactions, offering actionable insights to improve mental health and wellbeing.   Dr. Ben Rein is a neuroscientist, educator, and science communicator whose work explores the biology of human connection, empathy, and social behavior. With a Ph.D. in neuroscience and postdoctoral research at Stanford University, Dr. Rein has studied everything from the neural underpinnings of autism spectrum disorder to how MDMA (ecstasy) enhances empathy in the brain.   Follow his work at mindscience.org or connect with him on Instagram.   Links: Oxytocin (“the love hormone”) Loneliness and mortality studies Stanford University Lion's Mane   Show Notes: 00:00 Welcome back to the Hart2Heart podcast with Dr. Mike Hart 00:30 Dr. Ben Rein's background and new book 02:30 The loneliness epidemic and its effects 04:00 The science behind social interaction 04:15 “ Being isolated is worse for you or as bad for you as smoking 15 cigarettes a day.” 10:30 Extroversion vs. introversion: social needs 24:00 Oxytocin: the love hormone 33:00 Teamwork and social bonds 36:30 The power of tribalism in sports 38:00 Romantic relationships and health 42:00 The impact of loneliness across a lifetime 49:00 Social media and loneliness 01:02:00 The therapeutic potential of MDMA — The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to  cutting through the noise and uncovering the most effective strategies for optimizing health,  longevity, and peak performance. This podcast dives deep into evidence-based approaches to  hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise  protocols, leveraging sunlight light, and de-prescribing pharmaceuticals—using medications only when absolutely necessary.   Beyond health science, we tackle the intersection of public health and politics, exposing how  Policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being.   Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen).   If you're ready to take control of your health and performance, this is the podcast for you. We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect on social with Dr. Mike Hart: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

“When I was in medical school, no one had even heard of mitochondrial disease. Today, every student who graduates here knows what it is and has seen a patient with it,” says Dr. Mary Kay Koenig, director of the Center for the Treatment of Pediatric Neurodegenerative Disease at UTHealth Houston McGovern Medical School. That remarkable change in awareness has been accompanied by advances in genetic sequencing, the development of clinical guidelines, and the emergence of potential treatments in some forms of mitochondrial disease. In fact, Dr. Koenig's multidisciplinary team at UTHealth's Mitochondrial Center of Excellence has been a key player in clinical trials that may yield the first FDA-approved treatments for it. As you'll learn in this Year of the Zebra conversation with host Michael Carrese, her work in neurodegenerative diseases also includes tuberous sclerosis, where advanced therapies have replaced the need for repeated surgeries, and Leigh Syndrome, which has seen improvements in diagnoses and supportive therapies leading to better quality of life for patients.  Tune in as Dr. Koenig reflects on an era of progress in the space, the rewards of balancing research, teaching and patient care, and the need for more clinicians to center listening, humility and honesty in their approach to caring for rare disease patients and their  families.Mentioned in this episode:Mitochondrial Center of ExcellenceCenter for the Treatment of Pediatric Neurodegenerative Disease If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this solo episode, I share how learning to listen to my body became the most powerful form of self-trust. From discovering why men actually enjoy selfish women to revealing how an unexpected MDMA experience healed parts of my marriage, this episode is an intimate look at what it means to live, love, and lead on your own terms.✨ If you're craving deeper conversations, real connection, and conscious love Join UNION to meet potential matches at a dinner party in NYC + LAorSubscribe to Substack to stay in the loop about upcoming events, workshops, and retreats for conscious loveThis is the new era of love, self-led, embodied, and deeply connected

Are you enjoying this? Are you not? Tell us what to do more of, and what you'd like to hear less of. The Reykjavík Grapevine's Iceland Roundup brings you the top news with a healthy dash of local views. In this episode, Grapevine publisher Jón Trausti Sigurðarson is joined by Heimildin journalist Aðalsteinn Kjartansson, and Grapevine friend and contributor Sindri Eldon to roundup the stories making headlines in recent weeks. On the docket this week are: 00:00:55 Overview Of This Weeks Stories00:04:00 Strange Place Names In IcelandicWe discuss a random assortment of strange names of places in Iceland00:11:00 A Drunk Man Arrested For Taking A Nap On A Coast Guard ShipThe police arrested a man who had “taken up residence” in the the Icelandic coast guard ship Thor (Þór) this weekend. No further details were given about the incident.00:16:50 Iceland And Germany Sign A Defense AgreementOn Sunday, Þorgerður Katrín Gunnarsdóttir, Iceland's Minister for Foreign Affairs, and Boris Pistorius, Germany's Minister of Defense,  signed a bilateral declaration of intent on defense matters in connection with Pistorius' visit to Iceland. According to the declaration Iceland will build up infrastructure to accommodate military submarines and aircraft as a part of Iceland's membership in NATO. 00:21:40 Julian Assange Visits IcelandJulian Assange, the founder of Wikileaks, visited Iceland this weekend and was spotted at Vitabar, having a burger and fries. Assange, who was more or less in detention for 15 years was set free a year ago and now lives in Australia. 00:24:30 Drugs On A FerryThe only ferry to sale to Iceland on schedule, Norræna, which harbors in Seyðisfjörður, east Iceland, has been in the news recently for drugs. At the beginning of September, 7 kilos of cocaine were apprehended in a car on the ferry and two men arrested. Later in September, 15 kilos of Ketamine and 5 kilos of MDMA war found in another car on the ferry. Three people were arrested in the latter case.00:29:00 52% Think Church And State Should Be SeparatedA poll conducted recently tells us that 52% of Icelanders think that church and state should be separated. 27% are neither for nor against the motion, and 21% are opposed to separation. 00:39:40 Women's Strike 50th AnniversaryThis Friday, October 24th the famous 1975 Women's Strike turns 50. Tens of thousands are expected to celebrate this with a strike, and gather in downtown Reykjavík. ------------------------------------------------------------------------------------------SHOW SUPPORTSupport the Grapevine's reporting by becoming a member of our High Five Club: https://steadyhq.com/en/rvkgrapevine/You can also support the Grapevine by shopping in our online store: https://shop.grapevine.is------------------------------------------------------------------------------------------ This is a Reykjavík Grapevine podcast.The Reykjavík Grapevine is a free alternative magazine in English published 18 times per year, biweekly during the spring and summer, and monthly during the autumn and winter. The magazine covers everything Iceland-related, with a special focus culture, music, food and travel. The Reykjavík Grapevine's goal is to serve as a trustworthy and reliable source of information for those living in Iceland, visiting Iceland or interested in Iceland. Thanks to our dedicated readership and excellent distribution network, the Reykjavík Grapevine is Iceland's most read English-language publication. You may not agree with what we write or publish, but at least it's not sponsored content.www.grapevine.is

Today, Kati sits down with neuroscientist Dr. Ben Rein, to dive into the social connection and the growing loneliness epidemic. Dr. Rein, author of Why Brains Need Friends, explains how your brain is fundamentally wired for interaction, why isolation is a biological stressor, and what you can do to improve your social health. In this must-watch episode, Dr. Rein explains the mechanical changes happening in your brain during isolation and clarifies why the U.S. Surgeon General has declared a loneliness epidemic. You'll learn the surprising truth about isolation and physical health—it can cause stress hormones like cortisol to rise within days and is associated with more adverse health outcomes. Dr. Rein also reveals the science behind why isolation can make people more irritable and even angry, linking it to the body's natural stress response. Kati and Dr. Rein discuss the difference between in-person and digital interactions, noting that less "lifelike" communication strips away vital social cues like eye contact, body language, and even smell, leading to fewer mood benefits. Dr. Rein introduces the concept of a "Social Diet" and social journaling—practical tools to help you identify which interactions energize you ("breath in" relationships) versus those that leave you depleted. The conversation takes fascinating turns into the role of brain chemicals like oxytocin and serotonin in social reward and the development of empathy. Plus, discover the incredible, innate ability of dogs to detect physiological stress signals and the science of how pets help children develop crucial social skills. By shopping with our sponsors, you help support our podcast: Green Chef https://www.greenchef.com/50ASKKATI HeadSpace https://www.headspace.com/ASKKATI Timestamps 00:00 - Introduction to Dr. Ben Rein, neuroscientist and author of Why Brains Need Friends. 02:54 - The neuroscience behind loneliness-induced anger and why isolation is treated as a stressor by the body. 05:57 - Debunking the myth: Do introverts benefit from social interaction, and in what dose? 10:48 - The evolutionary reason we are wired for social reward, and the key brain chemicals involved: dopamine, oxytocin, and serotonin. 15:40 - A discussion on MDMA, serotonin depletion, and the severity of the drug's comedown. 21:11 - The shocking statistics on increasing time spent alone in modern society (36 hours more per month). 28:22 - What is "inter brain synchrony," and can it happen over a text message?. 35:47 - The power of social smells: how tears can reduce aggression and how a mother's scent affects a baby's brain synchrony. 41:51 - Why growing up with dogs helps children develop empathy and fewer conduct problems. 48:53 - The powerful therapeutic properties of oxytocin (anti-inflammatory, neuroprotective) beyond just social connection. Ask Kati Anything ep. 284 | Your mental health podcast, with Kati Morton, LMFT Today's guest is Dr. Ben Rein https://www.youtube.com/@dr.benrein Order Ben's new book Why Brains Need Friends → https://geni.us/WhyBrainsNeedFriends My new book Why Do I Keep Doing This? is available for pre-order! https://geni.us/XoyLSQ If you've ever felt stuck, this book is for you. I'd be so grateful for your support. MY BOOKS Traumatized https://geni.us/Bfak0j Are u ok? https://geni.us/sva4iUY ONLINE THERAPY (enjoy 10% off your first month) While I do not currently offer online therapy, BetterHelp can connect you with a licensed, online therapist: https://betterhelp.com/kati PARTNERSHIPS Nick Freeman | nick@biglittlemedia.co Disclaimer: The information provided in this video is for educational and informational purposes only and is not intended as medical or mental health advice. It should not be used to diagnose or treat any health problem or disease. Always consult with a qualified healthcare professional for diagnosis and treatment. Viewing this content does not establish a therapist-client relationship. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textI was really intrigued when I heard about Matt Zemon and his advocacy for psychedelic therapy as an alternative when traditional psychotherapy hasn't been successful. Colorado became the first state in the country to legalize therapy using psilocybin mushrooms, and I know someone who has done it and says it produced great results. Like many of you, I came from a place of complete ignorance on this topic, so I really appreciate Matt's expert knowledge on it, and he enlightened me on information like about the hundreds of psychedelic churches and societies in this country. He has a very broad knowledge of using medicines like psilocybin, ketamine, ayahuasca, MDMA, and other psychedelics, why for some people these are better than antidepressants, who should consider taking one of these, like veterans dealing with post-traumatic stress, or people wanting to explore spiritual growth, the research that has gone into psychedelics, government views and laws on them, and places where people can consult with professionals if they want to explore trying these medicines. In particular, Matt supports veteran communities with his book, “The Veteran's Guide to Psychedelic Journeys” helping them find more healing and hope by combining ancient healing traditions with contemporary practices. He is donating all of the book's proceeds to the Heroic Hearts Project, which further aids veterans to heal. It's a fascinating conversation that I would encourage you to listen to because it may resonate for you or someone you know, and it will open your eyes in a lot of unexpected ways.Matt Zemonmattzemon.comFacebook and Instagram @matt.zemonLinkedIn linkedin.com/in/mattzemonBill Stahlsilly_billy@msn.comFacebook Bill Stahl and American Heroes Run for race photosInstagram and Threads @stahlor and @we_are_superman_podcastYouTube We Are Superman PodcastSubscribe to the We Are Superman Newsletter!https://mailchi.mp/dab62cfc01f8/newsletter-signupSubscribe to our Substack for my archive of articles of coaching tips developed from my more than three decades of experience, wild and funny stories from my long coaching career, the wit and wisdom of David, and highlights of some of the best WASP episodes from the past that I feel are worthwhile giving another listen.Search either We Are Superman Podcast or @billstahl8

“Giving learners options gives them a better learning experience. It's more holistic and more comprehensive,” says Sean Moloney, CEO and founder of EmbodyXR, an extended reality platform focused on the use of immersive technologies in medical education. In this eye-opening Raise the Line conversation, Moloney explains how AI-powered extended reality (XR) --which integrates augmented, virtual, and simulation-based environments -- allows learners to interact with patients, explore multiple diagnostic choices, and experience varied outcomes based on their decisions. The result, he notes, is not only stronger engagement in learning, but a measurable improvement in understanding. Despite these gains, Moloney is quick to point out that he sees these technologies as complements to traditional training, not substitutes for it. “We'll never replace in-person teaching,” he says, “but we can make learners even better.” Beyond training future clinicians, the EmbodyXR platform is also offering new modes of patient and caregiver education, such as augmented reality guidance for using medical devices at home. Join host Lindsey Smith as she explores how EmbodyXR achieves and maintains clinical accuracy, the connectivity it offers between headsets, personal computers and mobile devices, and other capabilities that are shaping the future of how healthcare professionals and patients will learn. Mentioned in this episode:EmbodyXR If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

111. Trip Report: Kanna vs. MDMA Plus How Molly Effs With Your Sleep For WeeksWhat if you could feel more connected, relaxed, and joyful—without alcohol or MDMA? In this episode, I talk to Andrew Weisse, founder of getKanna and writer of Substack's The Psychedelic Blog, about the mood-enhancing, heart-opening power of Kanna, a South African plant that's gaining popularity as a functional empathogen. We discuss its chemical makeup, traditional use, and modern applications for social connection, romantic intimacy, and MDMA replacement. This is a big one for anyone exploring a sustainable way to engage with psychedelics.

In this episode, you'll discover:Whether mystical states are just neurons firing or something science can't explain yetWhy human morality keeps evolving and what that means for the stories we call truthHow to use technology to train your focus without losing the magic of transcendenceHave you ever noticed how the though ts that torture you most aren't even yours?They're hand-me-downs. Scripts you inherited from parents who inherited them from their parents. Cultural programming that told you productivity equals worth. That rest is laziness. That your value comes from how much you can do for everyone else. You've been running on these thoughts for so long you forgot they're just thoughts. Not truth. Just noise.Most people think meditation is about becoming calm. It's not. It's about seeing the machinery. The way your brain spins the same stories on repeat. The way it reaches for distraction the second discomfort shows up. The way it convinces you that scrolling Instagram or buying another thing or staying busy will make you feel better when really you're just running from yourself.I spent years doing that. Chasing experiences. MDMA, plant medicine, skydiving. Anything to feel something other than the hollow ache of not knowing who I was underneath all the performance. Those experiences cracked me open. But they didn't teach me how to stay open. That's what meditation did. It taught me that the version of me chasing dopamine hits wasn't broken. She was just afraid to sit still long enough to meet herself.Today our guest is Ariel Garten, neuroscientist, psychotherapist, and founder of Muse, the brain-sensing meditation headband. She's lived with undiagnosed ADD her whole life and used meditation and neuroscience to literally rewire her brain.Links from the episode:Show Notes: mindlove.com/423Join the Mind Love CollectiveSign up for The Morning Mind Love for short daily notes to wake up inspiredSupport Mind Love SponsorsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Why has America struggled so much to effectively manage the opioid use crisis? One of the answers, as you'll learn in this eye-opening episode of Raise the Line, is rooted in laws and attitudes from the early 20th century that removed addiction from the realm of medicine and defined it as a moral failing.  “The federal Harrison Act of 1914 forbade any physician from prescribing opioids to people with addiction, so it became more the purview of law enforcement or behavioral health or religion,” says Dr. Melody Glenn, who regularly confronts the consequences of this history during shifts in the emergency department at Banner-University Medical Center in Tucson, Arizona. And as Glenn explains to host Caleb Furnas, the resulting stigma associated with addiction has extended to the treatments for it as well, especially methadone, despite its effectiveness. Drawing on her dual expertise in emergency and addiction medicine, Glenn dispels misconceptions that medication-assisted treatment merely replaces one addiction with another, and emphasizes that harm reduction is critical to saving lives. Her desire to break prevailing stigmas led her to discover the story of Dr. Marie Nyswander, who pioneered methadone maintenance therapy in the 1960s and is featured in Dr. Glenn's new book, Mother of Methadone: A Doctor's Quest, a Forgotten History, and a Modern-Day Crisis. You'll leave this instructive interview understanding the roots of our flawed approach to addiction treatment, meeting an overlooked pioneer in the field, and admiring a devoted and compassionate physician who is following in her footsteps.  Mentioned in this episode:Banner-University Medical CenterMother of Methadone book If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Exploring Plant Medicine: Clinical Insights and Personal Transformation with Shawn Wells In this episode of the IRH Clinician's Corner, Margaret Floyd Barry welcomes back fan favorite Shawn Wells—an acclaimed nutritional biochemistry expert, supplement formulator, and author—for a fascinating conversation about the intersection of plant medicine and clinical practice. Margaret and Shawn dive into the rapidly evolving world of psychedelics, exploring both the science and profound personal transformations behind plant medicine. You will hear firsthand how these medicines can catalyze healing—emotionally, physically, and even relationally—providing fast-track breakthroughs for trauma, depression, and chronic stress.   In this interview, we discuss:       Shawn's personal journey with plant medicine and the changes that followed     How to approach and discuss the use of plant medicines in clinical practice     Types and levels of plant medicine and finding safe, competent facilitators      Preparing the body and mind for a plant medicine journey, as well as post-journey integration and support     How to support neuroplasticity and integration (through mindset and intention setting)     Microdosing: definitions and safe practices      Cautions and notes on practitioner responsibility The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/   Connect with Shawn Wells: Website: https://shawnwells.com/ Instagram: https://www.instagram.com/shawnwells/ Facebook: https://www.facebook.com/Ingredientologist LinkedIn: https://www.linkedin.com/in/shawn-wells-supplements/ YouTube: https://www.youtube.com/c/shawnwells Author of ‘The ENERGY Formula' https://shawnwells.com/theenergyformula/   Timestamps: 00:00 "Sean Wells: Supplement Innovator" 10:08 "Mind-Blowing Psychedelic Experience" 13:20 "Discovering Self-Worth and Love" 21:41 "Psychic Healing and Clinical Support" 25:35 Ketamine: Clinical Use for Healing 31:16 "Master Clinical Skills, Transform Health" 33:40 "Choosing the Right Facilitator" 43:11 "Post-Event Recovery Timing Discussed" 50:30 "Flaws in SSRI Effectiveness" 55:46 "Echo Dosing for Integration" 57:20 Echo Dose and Sensory Remembrance 01:10:42 Conclusion Speaker bio:  Shawn Wells, MPH, LDN, RD, CISSN, FISSN is a globally recognized nutritional biochemistry expert with more than 20 years of experience in health, wellness, and product formulation. He has formulated over 1,100 products and holds 40+ patents, including enfinity® (Paraxanthine) and BHB salts. He has served as Chief Clinical Dietitian, Chief Science Officer, and advisor to multiple supplement companies, facilitating transactions exceeding half a billion dollars. Shawn authored the bestselling book The Energy Formula, featured by USA Today and Forbes, and he shares cutting-edge research on Mindvalley, in documentaries, and on his website shawnwells.com. He frequently speaks at events globally. Keywords:  Functional health, clinical skills, chronic disease, supplement formulation, nutritional biochemistry, plant medicine, psychedelics, trauma, practitioner support, microdosing, ayahuasca, psilocybin, MDMA, ketamine, neuroplasticity, nervous system regulation, intention setting, integration, generational trauma, default mode network, BHB salt, ketones, adaptogens, methylated B vitamins, hydration, Condor Approach, facilitator training, set and setting, dietary preparation, psychotherapy, neurogenesis Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.  

Dr. K breaks down how psychedelics actually work not from hype or hearsay, but through neuroscience, psychiatry, and lived experience. He explains that psychedelics don't “heal” you by themselves; they temporarily put the brain into edit mode, a state of heightened neuroplasticity where your thoughts, emotions, and physiology can be rewritten for better or worse. Through a detailed look at serotonin receptors, brain connectivity, and decades of clinical research, Dr. K shows how substances like psilocybin, LSD, DMT, ayahuasca, and MDMA can rewire the brain and why they can just as easily cause harm if used without structure, safety, or integration. The episode also explores why guided psychedelic therapy — in a clinical or spiritual context — can lead to long-term healing, while unsupervised trips can lock trauma in even deeper. Dr. K ties it all together by connecting ego death to meditation and Vedic philosophy, revealing how both psychedelics and deep meditative practice dissolve the sense of self — and why that dissolution is often the real mechanism of healing. Topics include: The serotonin 2A receptor and why psychedelics increase neuroplasticity and neurogenesis How “edit mode” rewires your brain and how it can backfire Why integration therapy is critical after a psychedelic experience Set and setting: the real difference between healing and harm Which psychedelics work best for depression, PTSD, and addiction Why microdosing feels good but may not create long-term change The role of ego death and why it mirrors advanced meditation experiences Psychedelics vs. antidepressants - what the data actually says about efficacy and risk This episode is a deep dive into the science, safety, and spirituality of psychedelics offering clarity in a space often clouded by hype, myth, and misinformation. HG Coaching : https://bit.ly/46bIkdo Dr. K's Guide to Mental Health: https://bit.ly/44z3Szt HG Memberships : https://bit.ly/3TNoMVf Products & Services : https://bit.ly/44kz7x0 HealthyGamer.GG: https://bit.ly/3ZOopgQ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Diary of an Empath, I sit down with Dr. Ben Rein, a neuroscientist and science communicator, to explore the fascinating intersection between psychedelics and mental health.Dr. Rein breaks down what's actually happening in the brain when we use substances like psilocybin, MDMA, and ketamine—and how these compounds are being studied as potential treatments for depression, PTSD, and other mental health conditions.We dive deep into the science behind psychedelic therapy, the ethical considerations, and the importance of set and setting when it comes to healing safely and effectively. Dr. Rein also shares how social media has allowed him to make neuroscience more accessible to the public, bridging the gap between research and real-world understanding.This conversation challenges old stigmas, sheds light on groundbreaking research, and reminds us that healing isn't one-size-fits-all.In This Episode, We Discuss:What psychedelics do to the brain on a neurological levelThe latest research on psilocybin, MDMA, and ketamine in mental health treatmentThe potential benefits—and risks—of psychedelic therapyHow trauma and the nervous system interact with these substancesThe importance of intention, integration, and professional guidanceWhy education and accessibility are key to safe healingHow science communication on social media is changing the mental health landscapeDr. Ben Rein is a neuroscientist and science communicator whose work focuses on social behavior and mental health. He's known for translating complex research into digestible, relatable content on platforms like TikTok and Instagram, where he has built a massive community dedicated to understanding the brain and behavior.To get in Touch with Dr. Rein and to get a copy of his book:https://www.benrein.com/For psychic readings, Astrology, Therapy or Coaching with Keresse, click below:www.therapeutichealingbyreese.comFollow me on Instagram!https://instagram.com/_keresse_?utm_medium=copy_linkFollow me on Facebook!https://www.facebook.com/TherapeuticHealingByReese/TikTok:@DiaryofanEmpathpodcast

In this episode of Diary of an Empath, I sit down with Dr. Ben Rein, a neuroscientist and science communicator, to explore the fascinating intersection between psychedelics and mental health.Dr. Rein breaks down what's actually happening in the brain when we use substances like psilocybin, MDMA, and ketamine—and how these compounds are being studied as potential treatments for depression, PTSD, and other mental health conditions.We dive deep into the science behind psychedelic therapy, the ethical considerations, and the importance of set and setting when it comes to healing safely and effectively. Dr. Rein also shares how social media has allowed him to make neuroscience more accessible to the public, bridging the gap between research and real-world understanding.This conversation challenges old stigmas, sheds light on groundbreaking research, and reminds us that healing isn't one-size-fits-all.In This Episode, We Discuss:What psychedelics do to the brain on a neurological levelThe latest research on psilocybin, MDMA, and ketamine in mental health treatmentThe potential benefits—and risks—of psychedelic therapyHow trauma and the nervous system interact with these substancesThe importance of intention, integration, and professional guidanceWhy education and accessibility are key to safe healingHow science communication on social media is changing the mental health landscapeDr. Ben Rein is a neuroscientist and science communicator whose work focuses on social behavior and mental health. He's known for translating complex research into digestible, relatable content on platforms like TikTok and Instagram, where he has built a massive community dedicated to understanding the brain and behavior.To get in Touch with Dr. Rein and to get a copy of his book:https://www.benrein.com/For psychic readings, Astrology, Therapy or Coaching with Keresse, click below:www.therapeutichealingbyreese.comFollow me on Instagram!https://instagram.com/_keresse_?utm_medium=copy_linkFollow me on Facebook!https://www.facebook.com/TherapeuticHealingByReese/TikTok:@DiaryofanEmpathpodcast

Send us a textWhat happens when talk therapy isn't enough? When the pain runs so deep that even the best therapist can't reach it? Curt Kearney joins today to share his personal story of turning to psychedelics as a last resort and how that decision changed the entire trajectory of his life.This is a deeply grounded conversation about trauma, treatment-resistant depression, and the inner parts we exile to survive. Curt breaks down how Internal Family Systems (IFS) and psychedelic-assisted therapy can work together to bring those parts back into relationship, sometimes for the first time in decades. This is not a conversation about quick fixes. It's about safety, trust, and the power of showing up for the parts of ourselves we were taught to bury.This Episode Covers:Curt's first experience with LSD at 17 and how it altered his mental health journey.The difference between exiles and protectors in IFS.How psychedelics can amplify self-compassion and internal clarity.The importance of preparation and consent in psychedelic work.A powerful case study of MDMA-assisted therapy for PTSD.Why “bad trips” often come from neglected parts not feeling safe.The role of integration and ongoing relationship with inner parts.What happens when the monster inside turns out to be you.Connect with Curt:LinkedIn - https://www.linkedin.com/in/curt-kearney-39824643/Website - https://www.curtkearney.com/Until next time, here's to deeper connections and personal growth.Mad love!The podcast is now on YouTube! If you prefer to watch, head over to https://www.youtube.com/playlist?list=PLw3CabcJueib20U_L3WeaR-lNG_B3zYqu__________________________________________Don't forget to subscribe to the Badass Confidence Coach podcast on your favorite podcast platform!CONNECT WITH ANNA:Instagram https://www.instagram.com/askannamarcolin/TikTok https://www.tiktok.com/tag/askannamarcolinEmail hello@annamarcolin.comWebsite https://www.annamarcolin.com

Delanie Fischer chats with Dr. Dave Rabin, board-certified psychiatrist, translational neuroscientist, and inventor, to discuss the future of mental health and medicine. They discuss the efficacy of psychedelic-assisted therapy, technological therapeutics, ancient modalities, and ground-breaking discoveries about consciousness. * This episode is not a substitute for medical advice. Please consult your doctor to determine which therapeutic practices are appropriate for you. Plus: + The Root of Mental Illness, Epigenetics, Trauma, and Consciousness + Psychedelics & Medications: Psilocybin, Ketamine, MDMA, and SSRIs + Near-Death Experiences, Synchronicities, and Extrasensory Ability Self-Helpless on Patreon: https://www.patreon.com/selfhelpless Your Host, Delanie Fischer: https://www.delaniefischer.com EPISODES RELATED TO THIS TOPIC: Depression and Serotonin Syndrome with Dr. Tracey Marks: https://www.delaniefischer.com/selfhelplesspodcast/episode/36a8f408/depression-and-serotonin-syndrome-with-dr-tracey-marks Rethinking Intuition, Belief, and The Nature of Reality with Vincent Genna: https://www.delaniefischer.com/selfhelplesspodcast/episode/23db0212/rethinking-intuition-belief-and-the-nature-of-reality-with-vincent-genna 7 Reasons Why You May Have Insomnia (And How To Treat It) with Dr. Brian F. Licuanan: https://www.delaniefischer.com/selfhelplesspodcast/episode/215f937b/7-reasons-why-you-may-have-insomnia-and-how-to-treat-it-with-dr-brian-f-licuanan 20+ Years Thriving with Stage IV Cancer with Kris Carr: https://www.delaniefischer.com/selfhelplesspodcast/episode/22f2b084/20-years-thriving-with-stage-iv-cancer-with-kris-carr Learn more about your ad choices. Visit megaphone.fm/adchoices

After her father's sudden death, she carried a "calcified" grief for 15 years that traditional therapy couldn't touch—until one psychedelic cannabis journey changed everything. This week, we're joined by psychotherapist Angela, founder of Altered Healing, for a fascinating deep dive into the world of psychedelic therapy. Angela challenges the "Cheetos and cartoons" stereotype, making the case for cannabis as a powerful medicine for healing trauma when used with intention. We discuss her incredible personal story, the crucial difference between recreational and therapeutic use, and how cannabis compares to other medicines like ketamine, psilocybin, and MDMA.You can watch this entire episode over on YouTube!Follow Sickboy on Instagram, TikTok and Discord.

In this episode of the Intelligent Medicine podcast, host Dr. Ronald Hoffman discusses the increasing prevalence of depression and anxiety, particularly among young people, with guest Dr. Jacob Teitelbaum, Integrative Medicine physician, researcher, and best-selling author. They explore potential causes, including societal factors, diet, sleep patterns, and the fear-inducing media environment. Dr. Teitelbaum shares insights from his expertise in both conventional and integrative medicine, emphasizing the role of nutritional support, such as magnesium, B vitamins, and curcumin, as well as the importance of psychological strategies, biophysical techniques like shaking off trauma, and natural remedies. They also delve into the potential benefits of alternative therapies like CBD, ketamine, and psychedelics for mental health conditions. Listeners are encouraged to consider a comprehensive approach to managing these pervasive mental health issues.